» Articles » PMID: 34685518

Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction

Abstract

Myocardium Infarction (MI) is one of the foremost cardiovascular diseases (CVDs) causing death worldwide, and its case numbers are expected to continuously increase in the coming years. Pharmacological interventions have not been at the forefront in ameliorating MI-related morbidity and mortality. Stem cell-based tissue engineering approaches have been extensively explored for their regenerative potential in the infarcted myocardium. Recent studies on microfluidic devices employing stem cells under laboratory set-up have revealed meticulous events pertaining to the pathophysiology of MI occurring at the infarcted site. This discovery also underpins the appropriate conditions in the niche for differentiating stem cells into mature cardiomyocyte-like cells and leads to engineering of the scaffold via mimicking of native cardiac physiological conditions. However, the mode of stem cell-loaded engineered scaffolds delivered to the site of infarction is still a challenging mission, and yet to be translated to the clinical setting. In this review, we have elucidated the various strategies developed using a hydrogel-based system both as encapsulated stem cells and as biocompatible patches loaded with cells and applied at the site of infarction.

Citing Articles

Recent advances in adipose-derived mesenchymal stem cell-derived exosomes for regulating macrophage polarization.

Dong Z, Fu Y, Cai Z, Dai H, He Y Front Immunol. 2025; 16:1525466.

PMID: 39963133 PMC: 11830602. DOI: 10.3389/fimmu.2025.1525466.


Semiquantitative Cardiac-Specific Gene Expression Validation of the DNA Methylation Microarray in Human Mesenchymal Stem Cells.

Govarthanan K, Ramasamy D, Richard A, Kathirvelu D, Verma R Methods Mol Biol. 2025; 2880:147-158.

PMID: 39900757 DOI: 10.1007/978-1-0716-4276-4_6.


Current advances in the development of microRNA-integrated tissue engineering strategies: a cornerstone of regenerative medicine.

Castanon-Cortes L, Bravo-Vazquez L, Santoyo-Valencia G, Medina-Feria S, Sahare P, Duttaroy A Front Bioeng Biotechnol. 2024; 12:1484151.

PMID: 39479296 PMC: 11521876. DOI: 10.3389/fbioe.2024.1484151.


Growth differentiation factor 11 alleviates oxidative stress-induced senescence of endothelial progenitor cells via activating autophagy.

Tao P, Zhang H, Zhou P, Wang Y, Tan Y, Wang H Stem Cell Res Ther. 2024; 15(1):370.

PMID: 39420391 PMC: 11488219. DOI: 10.1186/s13287-024-03975-y.


Polyglycerol Sebacate/polycaprolactone/reduced graphene oxide composite scaffold for myocardial tissue engineering.

Rejali A, Ebrahimian-Hosseinabadi M, Kharazi A Heliyon. 2024; 10(19):e38672.

PMID: 39398017 PMC: 11470604. DOI: 10.1016/j.heliyon.2024.e38672.


References
1.
Chow A, Stuckey D, Kidher E, Rocco M, Jabbour R, Mansfield C . Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction. Stem Cell Reports. 2017; 9(5):1415-1422. PMC: 5830963. DOI: 10.1016/j.stemcr.2017.09.003. View

2.
Esmaeili R, Darbandi-Azar A, Sadeghpour A, Majidzadeh-A K, Eini L, Jafarbeik-Iravani N . Mesenchymal Stem Cells Pretreatment With Stromal-Derived Factor-1 Alpha Augments Cardiac Function and Angiogenesis in Infarcted Myocardium. Am J Med Sci. 2021; 361(6):765-775. DOI: 10.1016/j.amjms.2021.01.025. View

3.
Jeffords M, Wu J, Shah M, Hong Y, Zhang G . Tailoring material properties of cardiac matrix hydrogels to induce endothelial differentiation of human mesenchymal stem cells. ACS Appl Mater Interfaces. 2015; 7(20):11053-61. PMC: 4684185. DOI: 10.1021/acsami.5b03195. View

4.
Kuraitis D, Giordano C, Ruel M, Musaro A, Suuronen E . Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. Biomaterials. 2011; 33(2):428-43. DOI: 10.1016/j.biomaterials.2011.09.078. View

5.
Fleischer S, Feiner R, Dvir T . Cutting-edge platforms in cardiac tissue engineering. Curr Opin Biotechnol. 2017; 47:23-29. DOI: 10.1016/j.copbio.2017.05.008. View